| Detected | Trial | Change |
|---|---|---|
| 2026-08-02 | NCT05978024 Predicting Radiotherapy Response and Toxicities in Soft Tissue Sarcoma of the Extremities… |
overall status: Recruiting → Unknown |
| 2026-07-21 | NCT04360941 PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer |
date change Primary completion pushed: 2026-07-31 -> 2027-07-31 |
| 2026-07-21 | NCT04360941 PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer |
date change Completion pushed: 2026-07-31 -> 2027-07-31 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-03 | NCT07741929 Patient and Provider Perspectives on Genetic Risk Profiling | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT01584258 | Prostate Advances in Comparative Evidence | Prostate Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT04985266 | A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and… | ER+ Breast Cancer | Recruiting |
| NCT06560905 | Preoperative Planning With PSMA-PET in Melanoma Surgery Trial | Malignant Melanoma | Recruiting |
| NCT06250036 | Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer | Locally Advanced Gastric Adenocarcinoma | Recruiting |
| NCT02678182 | Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial | Adenocarcinoma of the Oesophagus | Active, Not Recruiting |
| NCT04920708 | Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer… | Metastatic Breast Cancer | Active, Not Recruiting |
| NCT07689955 | A Phase-II Clinical Trial of Radiotherapy to the Coeliac Plexus to Help Pain in Advanced… | Pancreatic Cancer | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT04166721 | WaKING: Wnt and checKpoint INhibition in Gastric Cancer | Metastatic Esophageal Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT04360941 | PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer | Triple Negative Breast Cancer | Recruiting |
| NCT02560636 | Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer | Invasive Bladder Cancer | Active, Not Recruiting |
| NCT02998567 | Combination Study of Guadecitabine/ASTX727 and Pembrolizumab | Non Small Cell Lung Cancer | Active, Not Recruiting |
| Not specified | |||
| NCT05118555 | Evaluation of New Magnetic Resonance Techniques | Magnetic Resonance Imaging | Recruiting |
| NCT05375591 | AI & Radiomics for Stratification of Lung Nodules After Radically Treated Cancer | Indeterminate Pulmonary Nodules | Recruiting |
| NCT05432739 | Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study | Lung Cancer | Recruiting |
| NCT05058183 | Safe De-escalation of Chemotherapy for Stage 1 Breast Cancer | Breast Cancer | Recruiting |
| NCT05709496 | Dose De-escalation in Prostate Radiotherapy Using the MRL | Prostate Adenocarcinoma | Recruiting |
| NCT06357416 | The Man Van Project | Prostate Cancer | Recruiting |
| NCT04050345 | Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer | Colorectal Cancer | Recruiting |
| NCT05933889 | Single and Combined Modality Trans-Oral Robotic Surgery in Early Oropharyngeal Cancer | Cancer Head Neck | Recruiting |
| NCT05644457 | Exploratory Study of Early Biomarkers Allowing Dynamic Assessment of Response to… | Head and Neck Cancer | Recruiting |
| NCT05645783 | Liquid Biopsy for Early DiagNosis of Squamous Cell Carcinoma of the HeAd and NeCk rEgion | Head and Neck Squamous Cell Carcinoma | Recruiting |
| NCT05734963 | ORganoid GeneratioN Study for Cancer | Cancer | Recruiting |
| NCT05837260 | Investigating Utility of ctDNA and Tumour Evolution in Advanced Thyroid Cancer | Thyroid Cancer | Recruiting |
| NCT06712095 | Video Capsule Examination in Patients With Lynch Syndrome | Lynch Syndrome | Recruiting |
| NCT06854679 | Dose Escalated Radiotherapy for Rectal Cancers Using MR-guided Radiotherapy | Rectal Adenocarcinoma | Recruiting |